Buoyant market for magnetic resonance imaging (MRI) contrast media in Japan:
This article was originally published in Clinica
The Japanese market for MRI contrast media is worth around ¥0,000 million ($91 million) at official reimbursement prices, estimates Japan Medical Review. This is forecast to rise to Yen17,000 million by 1998, reflecting the expected growth of MRI scanning and increase in the number of scanners in Japan. Daiichi, which recently launched Nycomed's MRI contrast agent, Omniscan, in Japan (see Clinica No 713, p 9), estimates Omniscan sales will total Yen1,500 million in its first year on the market, rising to Yen4,000 million by 1998.